CorMedix Inc. — Director's Dealing 2010

Mar 29, 2010

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2010-03-24

Reporting Person: ELLISON RUSSELL H (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$8.2300	2018-08-01	Common Stock, $0.001 par value per share (15314)		Direct

Footnotes

F1: These options vest as follows: 1/3 on March 4, 2009; an additional 1/3 on March 4, 2010; and the remaining 1/3 on March 4, 2011.